Articles
| Open Access |
DOI: Transurethral Resection Of En-Bloс Muscularis Non - Invasive Bladder Cancer
Mirzagaleb Nigmatovich Tillashayhov , Doctor Of Medical Sciences, Professor, Professor, Director Of The Republican Specialized Scientific-Practical Medical Center Of Oncology And Radiology Of The Ministry Of Health Of The Republic Of Uzbekistan Elena Vladimirovna Boyko , Candidate Of Medical Sciences, Head Of The Department Of The Republican Specialized Scientific And Practical Medical Centre For Oncology And Radiology, Tashkent, Uzbekistan Ravshan Abdurasulovich Khashimov , Doctor At The Republican Specialised Scientific And Practical Medical Centre For Oncology And Radiology, Tashkent, Uzbekistan Nodir Mahammatkulovich Rakhimov , Associate Professor Of Oncology Department Of Samarkand Medical Institute, Tashkent, UzbekistanAbstract
The high recurrence rate of muscle noninvasive bladder cancer (BC) dictates the search for new methods of surgical treatment. The problem of bladder cancer (BC) treatment is very urgent in urology, because of high morbidity, difficulties in determining the optimal treatment tactics, necessity of long-term follow-up examinations, high recurrence rate and progression. Risk and progression criteria have been developed to identify groups of patients in need of closer follow-up, which can be quantified using risk calculators for recurrence and tumour progression. Although there are clear guidelines for the treatment of patients with bladder cancer, it is also believed that the rate of recurrence depends on the quality of the primary surgical procedure performed [1,2].
Keywords
Bladder tumours, single unit, standard transurethral resection
References
Yusupbekov, A. A., Rakhimov, N. M., & Yigitaliev, A. B. (2020). Factors of prediction of non-dedicated survival in patients with muscular-non-invasive bladder cancer. International Journal of Discourse on Innovation, Integration and Education, 1 (5), 212-215.
Kamalova, M., & Khaidarov, N. (2021). Assessment of quality of life in ischaemic stroke patients. Збірник наукових праць Scientia.
Shomurodov. K.E. (2010). Features of cytokine balance in gingival fluid at odontogenicphlegmon of maxillofacial area. Doctor-aspirant. 42 Vol. No.5.1. pp.187-192.
Tillyashaykhov M. N., Rakhimov N. M. Khasanov Sh. T., (2019). Features of Clinical Manifestation of the bladder cancer in young people. Doctor Bulletin. Samarkand,. №2. pp. 108-113.
Ilkhomovna, K. M., Eriyigitovich, I. S., & Kadyrovich, K. N. (2020). Morphological Features Of Microvascular Tissue Of The Brain At Hemorrhagic Stroke. The American Journal of Medical Sciences and Pharmaceutical Research, 2(10), 53-59.
Ziyadullaev, S., Elmamatov, O., Raximov, N., & Raufov, F. (2020). Cytogenetic and immunological alterations of recurrent bladder cancer. European Journal of Molecular & Clinical Medicine, 7(2), 1877-1883.
Tillyashaykhov M, Rakhimov N, Boyko E, Ravshan Kh. (2020). Comparative characteristics of en-block resection and conventional transurethral resection in nonmuscular invasive bladder cancer (metaanalysis). Journal of Biomedicine and Practice, vol. 6, issue 5, pp.124-131.
Rahimov M. Nodir, Shakhanova Sh. Shaxnoza, Raupov Farhod. (2020). Development of new approaches in treatment of metastatic renal cell carcinoma. Journal of research in health science. 5(4), pp.82-95.
Saidkulov, B., Abduraxmonov, A., & Rahimov, N. (2020). Recurrent ovarian cancer: mechanisms of development of peritoneal malignant ascites. European Journal of Molecular & Clinical Medicine ISSN, 2515-8260.
Rahimov N., Shakhanova Sh. (2020). Development of new approaches in treatment of metastatic renal cell carcinoma. Journal of research in health science 5-6(4), pp. 82-95.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.